Tacedinaline Completed Phase 3 Trials for Lung Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00005093Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer